Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rxo (RXO) Net Cash Flow (2021 - 2025)

Rxo (RXO) has disclosed Net Cash Flow for 5 consecutive years, with -$8.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Net Cash Flow rose 55.56% year-over-year to -$8.0 million, compared with a TTM value of -$19.0 million through Dec 2025, down 159.38%, and an annual FY2025 reading of -$19.0 million, down 159.38% over the prior year.
  • Net Cash Flow was -$8.0 million for Q4 2025 at Rxo, down from $7.0 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $166.0 million in Q2 2022 and bottomed at -$100.0 million in Q4 2023.
  • Average Net Cash Flow over 5 years is -$687500.0, with a median of $500000.0 recorded in 2021.
  • The sharpest move saw Net Cash Flow crashed 8600.0% in 2022, then skyrocketed 352.63% in 2024.
  • Year by year, Net Cash Flow stood at -$1.0 million in 2021, then plummeted by 8600.0% to -$87.0 million in 2022, then decreased by 14.94% to -$100.0 million in 2023, then soared by 82.0% to -$18.0 million in 2024, then skyrocketed by 55.56% to -$8.0 million in 2025.
  • Business Quant data shows Net Cash Flow for RXO at -$8.0 million in Q4 2025, $7.0 million in Q3 2025, and $2.0 million in Q2 2025.